Skip to main content
Loading
9:00 AM
  1. Franciscan B/C/D
    180 mins

    Attend 13-minute presentations across several therapeutic areas.
     

11:00 AM
  1. Imperial Ballroom
    50 mins
    The ability of bispecific antibodies and antibody drug conjugates to interact with two biologic binding sites at once creates major leverage for interfering with a disease mechanism intercellularly as ...
1:00 PM
  1. Franciscan B/C/D
    240 mins
    Attend 13-minute presentations across several therapeutic areas.
  2. Imperial Ballroom
    50 mins
    More than 130 human health companies are in SOSV's portfolio, and more than 30 of those are pre-series-A biopharma start-ups in IndieBio's program. Mohan Iyer is a General Partner at SOSV’s IndieBio S ...
3:00 PM
  1. Imperial Ballroom
    50 mins
    Within the past five years, RNA technologies have demonstrated they can improve patients’ health by transforming gene expression and open a successful new frontier for infectious disease vaccine devel ...
4:00 PM
  1. Imperial Ballroom
    50 mins
    A recent article noted that the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028. With some of the world’s most populous countries, the need ...
9:00 AM
  1. Franciscan B/C/D
    180 mins
    Attend 13-minute presentations across several therapeutic areas.
10:00 AM
  1. Imperial Ballroom
    50 mins
    Since the passage of the Inflation Reduction Act, companies, investors, and patients have raised concerns about how the legislation will impact innovation in the biotech industry. Will there be a decl ...
11:00 AM
  1. Imperial Ballroom
    50 mins
    A Nature biotechnology report cited an analysis of the 25 most active VC firms that shows less than 1% of senior level investment teams have partners from underrepresented racial and ethnic groups. Mc ...
12:00 PM
  1. Imperial Ballroom
    50 mins
    Dr. Julia Owens is an experienced biopharmaceutical CEO and board member with a deep commitment to advancing innovative therapies for patients over a 20+ year professional career. She brings a unique ...
1:00 PM
  1. Franciscan B/C/D
    240 mins
    Attend 13-minute presentations across several therapeutic areas.
  2. Imperial Ballroom
    50 mins
    Relative to other highly prevalent diseases such as cancers or cardiovascular disease, companies seeking therapies for neurodegeneration have struggled with drug delivery and biomarker validation insi ...
2:00 PM
  1. Imperial Ballroom
    50 mins
    Last year, Google’s AlphaFold project demonstrated it can model more than 200 million molecular 3-D structures, including nearly all known proteins, by applying computational biology and artificial in ...

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS